ACS Nano · 2023 · 30 citations · 28 references
PharmacyMedicinal ChemistryPharmacologyDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryDrug EncapsulationNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignTargeted Prodrug DeliveryAntiplatelet DrugsBoronic Acid ProdrugsDrug Delivery NanocarriersMultifunctional NanoparticlesNanocarrier-based ProdrugsProdrug NanoparticlesSelf-immolative Drug Delivery SystemsTargeted Drug Delivery Prodrugs
All trans -retinoic acid (atRA) has potent anti-inflammatory and antiplatelet activity, but its clinical translation as an antithrombotic drug has been hampered by its low therapeutic efficacy. Here, we describe a facile and elegant strategy that converts atRA into systemically injectable antithrombotic nanoparticles. The strategy involves the dimerization of two atRA molecules using a self-immolative boronate linker that is cleaved specifically by hydrogen peroxide (H 2 O 2 ) to release anti-inflammatory hydroxybenzyl alcohol (HBA), followed by dimerization-induced self-assembly to generate colloidally stable nanoparticles. The boronated atRA dimeric prodrug (BRDP) could form injectable nanoparticles in the presence of fucoidan that serves as an emulsifier and a targeting ligand to P-selectin overexpressed on the damaged endothelium. In response to H 2 O 2, fucoidan-decorated BRDP (f-BRDP) nanoassemblies dissociate to release both atRA and HBA, while scavenging H 2 O 2 . In a mouse model of ferric chloride (FeCl 3 )-induced carotid arterial thrombosis, f-BRDP nanoassemblies target the thrombosed vessel and significantly inhibit thrombus formation. The results demonstrate that dimerization of atRA molecules via a boronate linker enables the formation of stable nanoassemblies with several benefits: high drug loading, drug self-delivery, on-demand multiple antithrombotic actions, and simple fabrication of nanoparticles. Overall, this strategy provides a promising expedient and practical route for the development of translational self-deliverable antithrombotic nanomedicine.
28
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
Bingjun Sun, Cong Luo, Yu Han et al. · Nano Letters · 2018 · 411 citations
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
Bingjun Sun, Cong Luo, Xuanbo Zhang et al. · Nature Communications · 2019 · 321 citations · Full text
Pharmacy, Oncology, Pharmacology +17